Notice Information
Notice Title
Cytek Aurora spectral cytometer
Notice Description
The Clinical Immunology Service (CIS) provides a comprehensive Clinical Immunology diagnostics service to the West Midlands, regional services in lymphoma/leukaemia diagnosis and national services for neuro-immunology and myeloma testing. Being situated within the University of Birmingham (UoB), the CIS also provides central trials analysis for a number of national and local research studies and has a strong track record in immunodiagnostic development. The CIS is the anchor tenant for the Precision Health Technologies Accelerator (PHTA) Home - PHTA Ltd, hosted within the Birmingham Health Innovation Campus (BHIC) Birmingham Health Innovation Campus - Birmingham Health Partners. This ambitious new development will leverage the existing Birmingham Health Partners ecosystem to drive innovation and economic growth. The CIS has built a nationally leading reputation based on our foundations of quality and delivery and has the expertise, reputation, and networks to progress towards being a global leader in diagnostic development, translation and testing. This supports UoB's ambition to become a global top 50 University and contributes towards the success of the PHTA and BHIC. To ensure the CIS not only remains able to deliver and maintain current business and workload, but also to ensure it can sustain delivery during the move to the PHTA and deliver the anticipated growth in the future, we need to continually update our equipment and methods to ensure improved efficiency, quality and capabilities. The CIS is a UKAS ISO15189 accredited laboratory offering comprehensive blood cancer, autoimmunity, neuroimmunology, immunodeficiency and allergy diagnostic services to local and national NHS services. Additionally, the CIS hosts the Midlands Integrated Reporting for Haemato-oncology (MIRHO), a blood cancer diagnostic service, providing blood cancer flow cytometry to the whole of West Midlands; this is an area of ensured increased growth as new therapies are commenced and survival improves for blood cancer patients. To support the growth and development of this service we need to update our flow cytometry platforms and methods. We therefore intend to purchase a Cytek Aurora spectral cytometer.
Lot Information
Lot 1
The Clinical Immunology Service (CIS) provides a comprehensive Clinical Immunology diagnostics service to the West Midlands, regional services in lymphoma/leukaemia diagnosis and national services for neuro-immunology and myeloma testing. Being situated within the University of Birmingham (UoB), the CIS also provides central trials analysis for a number of national and local research studies and has a strong track record in immunodiagnostic development. The CIS is the anchor tenant for the Precision Health Technologies Accelerator (PHTA) Home - PHTA Ltd, hosted within the Birmingham Health Innovation Campus (BHIC) Birmingham Health Innovation Campus - Birmingham Health Partners. This ambitious new development will leverage the existing Birmingham Health Partners ecosystem to drive innovation and economic growth. The CIS has built a nationally leading reputation based on our foundations of quality and delivery and has the expertise, reputation, and networks to progress towards being a global leader in diagnostic development, translation and testing. This supports UoB's ambition to become a global top 50 University and contributes towards the success of the PHTA and BHIC. To ensure the CIS not only remains able to deliver and maintain current business and workload, but also to ensure it can sustain delivery during the move to the PHTA and deliver the anticipated growth in the future, we need to continually update our equipment and methods to ensure improved efficiency, quality and capabilities. The CIS is a UKAS ISO15189 accredited laboratory offering comprehensive blood cancer, autoimmunity, neuroimmunology, immunodeficiency and allergy diagnostic services to local and national NHS services. Additionally, the CIS hosts the Midlands Integrated Reporting for Haemato-oncology (MIRHO), a blood cancer diagnostic service, providing blood cancer flow cytometry to the whole of West Midlands; this is an area of ensured increased growth as new therapies are commenced and survival improves for blood cancer patients. To support the growth and development of this service we need to update our flow cytometry platforms and methods. We therefore intend to purchase a Cytek Aurora spectral cytometer.
Procurement Information
* Matching component conformity, configuration, instrument settings, acquisition software and IVDR antibody panels (including disease specific panels, e.g. AML) with the Cytek Northern Lights IVD instrument that we are already evaluating in CIS. To the best of our knowledge these are the only available IVD spectral cytometer/validated IVDR antibody panels on the market. This will allow rapid development of new panels for routine immunophenotyping in our clinical diagnostic laboratory with minimal additional training. * 60+ detection channels for fluorochromes across a broad range of wavelengths, even when peak emission wavelengths show high degrees of overlap. For example, we would like to simultaneously use Pacific Blue, BV421, SuperBright 436 and BV480 in a single tube panel. To our knowledge, this is only feasible with the 5 laser Aurora instrument. * Antibody reagent options for pre-built multicolour panels (>20 colours) that have been optimized with the instrument. To our knowledge, these are only available for Cytek instruments. * Characterizing small particles such as extracellular vesicles, with resolution down to 70nm.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-04498d
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/008532-2024
- Current Stage
- Award
- All Stages
- Award
Procurement Classification
- Notice Type
- Award Notice
- Procurement Type
- Standard
- Procurement Category
- Goods
- Procurement Method
- Limited
- Procurement Method Details
- Negotiated without publication of a contract notice
- Tender Suitability
- Not specified
- Awardee Scale
- SME
Common Procurement Vocabulary (CPV)
- CPV Divisions
38 - Laboratory, optical and precision equipments (excl. glasses)
-
- CPV Codes
38434510 - Cytometers
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- £311,004 £100K-£500K
Notice Dates
- Publication Date
- 15 Mar 20241 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- Not specified
- Award Date
- 15 Mar 20241 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Not Specified
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- THE UNIVERSITY OF BIRMINGHAM
- Contact Name
- Available with D3 Tenders Premium →
- Contact Email
- Available with D3 Tenders Premium →
- Contact Phone
- Available with D3 Tenders Premium →
Buyer Location
- Locality
- BIRMINGHAM
- Postcode
- B15 2TT
- Post Town
- Birmingham
- Country
- England
-
- Major Region (ITL 1)
- TLG West Midlands (England)
- Basic Region (ITL 2)
- TLG3 West Midlands
- Small Region (ITL 3)
- TLG31 Birmingham
- Delivery Location
- TLG31 Birmingham
-
- Local Authority
- Birmingham
- Electoral Ward
- Edgbaston
- Westminster Constituency
- Birmingham Edgbaston
Further Information
Notice URLs
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-04498d-2024-03-15T16:43:27Z",
"date": "2024-03-15T16:43:27Z",
"ocid": "ocds-h6vhtk-04498d",
"initiationType": "tender",
"tender": {
"id": "SC12413/24",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "Cytek Aurora spectral cytometer",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "38434510",
"description": "Cytometers"
},
"mainProcurementCategory": "goods",
"description": "The Clinical Immunology Service (CIS) provides a comprehensive Clinical Immunology diagnostics service to the West Midlands, regional services in lymphoma/leukaemia diagnosis and national services for neuro-immunology and myeloma testing. Being situated within the University of Birmingham (UoB), the CIS also provides central trials analysis for a number of national and local research studies and has a strong track record in immunodiagnostic development. The CIS is the anchor tenant for the Precision Health Technologies Accelerator (PHTA) Home - PHTA Ltd, hosted within the Birmingham Health Innovation Campus (BHIC) Birmingham Health Innovation Campus - Birmingham Health Partners. This ambitious new development will leverage the existing Birmingham Health Partners ecosystem to drive innovation and economic growth. The CIS has built a nationally leading reputation based on our foundations of quality and delivery and has the expertise, reputation, and networks to progress towards being a global leader in diagnostic development, translation and testing. This supports UoB's ambition to become a global top 50 University and contributes towards the success of the PHTA and BHIC. To ensure the CIS not only remains able to deliver and maintain current business and workload, but also to ensure it can sustain delivery during the move to the PHTA and deliver the anticipated growth in the future, we need to continually update our equipment and methods to ensure improved efficiency, quality and capabilities. The CIS is a UKAS ISO15189 accredited laboratory offering comprehensive blood cancer, autoimmunity, neuroimmunology, immunodeficiency and allergy diagnostic services to local and national NHS services. Additionally, the CIS hosts the Midlands Integrated Reporting for Haemato-oncology (MIRHO), a blood cancer diagnostic service, providing blood cancer flow cytometry to the whole of West Midlands; this is an area of ensured increased growth as new therapies are commenced and survival improves for blood cancer patients. To support the growth and development of this service we need to update our flow cytometry platforms and methods. We therefore intend to purchase a Cytek Aurora spectral cytometer.",
"lots": [
{
"id": "1",
"description": "The Clinical Immunology Service (CIS) provides a comprehensive Clinical Immunology diagnostics service to the West Midlands, regional services in lymphoma/leukaemia diagnosis and national services for neuro-immunology and myeloma testing. Being situated within the University of Birmingham (UoB), the CIS also provides central trials analysis for a number of national and local research studies and has a strong track record in immunodiagnostic development. The CIS is the anchor tenant for the Precision Health Technologies Accelerator (PHTA) Home - PHTA Ltd, hosted within the Birmingham Health Innovation Campus (BHIC) Birmingham Health Innovation Campus - Birmingham Health Partners. This ambitious new development will leverage the existing Birmingham Health Partners ecosystem to drive innovation and economic growth. The CIS has built a nationally leading reputation based on our foundations of quality and delivery and has the expertise, reputation, and networks to progress towards being a global leader in diagnostic development, translation and testing. This supports UoB's ambition to become a global top 50 University and contributes towards the success of the PHTA and BHIC. To ensure the CIS not only remains able to deliver and maintain current business and workload, but also to ensure it can sustain delivery during the move to the PHTA and deliver the anticipated growth in the future, we need to continually update our equipment and methods to ensure improved efficiency, quality and capabilities. The CIS is a UKAS ISO15189 accredited laboratory offering comprehensive blood cancer, autoimmunity, neuroimmunology, immunodeficiency and allergy diagnostic services to local and national NHS services. Additionally, the CIS hosts the Midlands Integrated Reporting for Haemato-oncology (MIRHO), a blood cancer diagnostic service, providing blood cancer flow cytometry to the whole of West Midlands; this is an area of ensured increased growth as new therapies are commenced and survival improves for blood cancer patients. To support the growth and development of this service we need to update our flow cytometry platforms and methods. We therefore intend to purchase a Cytek Aurora spectral cytometer.",
"hasOptions": false
}
],
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"region": "UKG31"
}
],
"relatedLot": "1"
}
],
"procurementMethod": "limited",
"procurementMethodDetails": "Negotiated without publication of a contract notice",
"coveredBy": [
"GPA"
],
"procurementMethodRationaleClassifications": [
{
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
"id": "D_ARTISTIC",
"description": "The works, supplies or services can be provided only by a particular economic operator due to procurement aiming at the creation or acquisition of a unique work of art or artistic performance"
}
],
"procurementMethodRationale": "* Matching component conformity, configuration, instrument settings, acquisition software and IVDR antibody panels (including disease specific panels, e.g. AML) with the Cytek Northern Lights IVD instrument that we are already evaluating in CIS. To the best of our knowledge these are the only available IVD spectral cytometer/validated IVDR antibody panels on the market. This will allow rapid development of new panels for routine immunophenotyping in our clinical diagnostic laboratory with minimal additional training. * 60+ detection channels for fluorochromes across a broad range of wavelengths, even when peak emission wavelengths show high degrees of overlap. For example, we would like to simultaneously use Pacific Blue, BV421, SuperBright 436 and BV480 in a single tube panel. To our knowledge, this is only feasible with the 5 laser Aurora instrument. * Antibody reagent options for pre-built multicolour panels (>20 colours) that have been optimized with the instrument. To our knowledge, these are only available for Cytek instruments. * Characterizing small particles such as extracellular vesicles, with resolution down to 70nm."
},
"awards": [
{
"id": "008532-2024-1",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-108012",
"name": "Cytek Biosciences B.V"
}
]
}
],
"parties": [
{
"id": "GB-COH-RC000645",
"name": "THE UNIVERSITY OF BIRMINGHAM",
"identifier": {
"legalName": "THE UNIVERSITY OF BIRMINGHAM",
"id": "RC000645",
"scheme": "GB-COH"
},
"address": {
"streetAddress": "Edgbaston",
"locality": "BIRMINGHAM",
"region": "UKG31",
"postalCode": "B152TT",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "Kseniya Samsonik",
"email": "k.samsonik@bham.ac.uk"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.birmingham.ac.uk/",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "09",
"description": "Education"
}
]
}
},
{
"id": "GB-FTS-108012",
"name": "Cytek Biosciences B.V",
"identifier": {
"legalName": "Cytek Biosciences B.V",
"id": "74997823",
"schemeEntered": "Cytek Biosciences B.V"
},
"address": {
"locality": "Amsterdam",
"region": "NL",
"countryName": "Netherlands"
},
"roles": [
"supplier"
],
"details": {
"scale": "sme"
}
},
{
"id": "GB-FTS-73658",
"name": "University of Birmingham",
"identifier": {
"legalName": "University of Birmingham"
},
"address": {
"locality": "Edgbaston",
"countryName": "United Kingdom"
},
"roles": [
"reviewBody"
]
}
],
"buyer": {
"id": "GB-COH-RC000645",
"name": "THE UNIVERSITY OF BIRMINGHAM"
},
"contracts": [
{
"id": "008532-2024-1",
"awardID": "008532-2024-1",
"status": "active",
"value": {
"amount": 311004.45,
"currency": "GBP"
},
"dateSigned": "2024-03-15T00:00:00Z"
}
],
"language": "en"
}